Cargando…

Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome

OBJECTIVE: To explore whether gene expression profiling can identify a molecular mechanism for the clinical benefit of canakinumab treatment in patents with tumour necrosis factor receptor-associated periodic syndrome (TRAPS). METHODS: Blood samples were collected from 20 patients with active TRAPS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torene, Rebecca, Nirmala, Nanguneri, Obici, Laura, Cattalini, Marco, Tormey, Vincent, Caorsi, Roberta, Starck-Schwertz, Sandrine, Letzkus, Martin, Hartmann, Nicole, Abrams, Ken, Lachmann, Helen, Gattorno, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Basic and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264306/ https://www.ncbi.nlm.nih.gov/pubmed/27474763 http://dx.doi.org/10.1136/annrheumdis-2016-209335

Ejemplares similares

Gene expression profiling in understanding the molecular pathogenesis of and response to canakinumab therapy in traps
por: Gattorno, M, et al.
Publicado: (2014)

Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
por: Gattorno, Marco, et al.
Publicado: (2017)

OR10-006 - Canakinumab in patients with TRAPS
por: Lachmann, HJ, et al.
Publicado: (2013)

Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study
por: Lachmann, H, et al.
Publicado: (2015)

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
por: Papa, Riccardo, et al.
Publicado: (2020)

Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials
por: Letzkus, Martin, et al.
Publicado: (2014)

The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
por: Caorsi, Roberta, et al.
Publicado: (2013)

Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
por: Caorsi, R, et al.
Publicado: (2011)

A circulating reservoir of pathogenic-like CD4(+) T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment
por: Spreafico, Roberto, et al.
Publicado: (2016)

Growth dynamics of brain metastases differentiate radiation necrosis from recurrence
por: Ocaña-Tienda, Beatriz, et al.
Publicado: (2022)

TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis
por: Rossetti, Maura, et al.
Publicado: (2017)

MR1 overexpression correlates with poor clinical prognosis in glioma patients
por: Kubica, Phillip, et al.
Publicado: (2021)

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway
por: González-Alvaro, I, et al.
Publicado: (2008)

Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein
por: Munoz Pinto, Mario F, et al.
Publicado: (2021)

Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β
por: Galant, Christine, et al.
Publicado: (2019)

Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice
por: Qin, Yuan, et al.
Publicado: (2020)

Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor α (WSX-1)
por: Sugiyama, N, et al.
Publicado: (2008)

Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in mice
por: Aarts, Joyce, et al.
Publicado: (2020)

Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy
por: Brachat, Arndt H., et al.
Publicado: (2017)

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study
por: Buch, M H, et al.
Publicado: (2009)

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
por: Antón, J, et al.
Publicado: (2013)

Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma
por: Wang, Zihao, et al.
Publicado: (2023)

GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
por: Ajaib, Shoaib, et al.
Publicado: (2023)

Expedited Desensitization to Canakinumab
por: Sanan, Neha, et al.
Publicado: (2020)

NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma
por: Juvvuna, Prasanna Kumar, et al.
Publicado: (2021)

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
por: Ombrello, Michael J, et al.
Publicado: (2017)

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
por: Behling, Felix, et al.
Publicado: (2020)

Leukocyte toll-like receptor expression in pathergy positive and negative Behçet’s disease patients
por: van der Houwen, Tim B, et al.
Publicado: (2020)

Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients—a potential biomarker of disease activity
por: Stratigou, Victoria, et al.
Publicado: (2017)

Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
por: Merz, Felicitas, et al.
Publicado: (2013)

Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response
por: Pizzocri, Marco, et al.
Publicado: (2021)

Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
por: Friedrich, Mirco, et al.
Publicado: (2022)

Pharmacokinetics of Canakinumab in children younger than 2 years old with CAPS
por: Kalabus, J, et al.
Publicado: (2015)

Monogenic polyarteritis: the lesson of ADA2 deficiency
por: Caorsi, Roberta, et al.
Publicado: (2016)

Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas
por: Bettegowda, Chetan, et al.
Publicado: (2019)

Preoperative imaging of glioblastoma patients using hyperpolarized (13)C pyruvate: Potential role in clinical decision making
por: Chen, Jun, et al.
Publicado: (2021)

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
por: Bader-Meunier, B, et al.
Publicado: (2011)

Pediatric high-grade gliomas and the WHO CNS Tumor Classification—Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates
por: Gielen, Gerrit H, et al.
Publicado: (2022)

Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement
por: Chang, Ken, et al.
Publicado: (2019)

Canakinumab and Lung Cancer: Intriguing, but Is It Real?
por: Chabner, Bruce A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sopn0lccbhrmpi9p5une83mhsq